About Pamela Jones, MD

Pamela Jones, MD MS MPH, is a neurosurgeon who cares for people with all types of brain tumors, including glioblastoma, low and high-grade gliomas, metastatic brain tumors, and skull base tumors such as meningiomas and pituitary tumors. Her expertise includes performing minimally-invasive endoscopic neurosurgery for treating tumors in the skull base and pituitary. She also specializes in the treatment of brain tumors affecting the language and motor areas of the brain that may require awake brain surgery, language and motor mapping, and subcortical stimulation. 

Dr. Jones returned to the MGH in 2017 after being an assistant professor at UCSD with a clinical practice focused in neuro-oncology and skull base disease. Dr. Jones completed residency training in neurosurgery at the Massachusetts General Hospital. Her fellowship training in pituitary and endoscopic skull base was also performed at the Massachusetts General Hospital and the Massachusetts Eye and Ear Infirmary under Dr. Brooke Swearingen and Dr. William Curry. Dr. Jones earned her medical degree from Tulane University School of Medicine, graduating with Alpha Omega Alpha honors. She attended Stanford University for her undergraduate degree in biology. She also holds a master’s degree in public health from Harvard School of Public Health and a master’s degree in biomedical journalism from New York University.

 

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Locations

Mass General Neurosurgery
55 Fruit St.
Wang Ambulatory Care Center
Suite 331
Boston, MA 02114
Phone: 617-724-9117
Fax: 617-643-4113

Medical Education

  • MD, Tulane University School of Medicine

American Board Certifications

  • Neurological Surgery, American Board of Neurological Surgery

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

Dr. Pamela Jones’ research focuses on neurosurgical outcomes and clinical trials, particularly within brain tumor and pituitary tumor, as well as quality and safety improvement initiatives.

Reviews: Comments and Ratings